で公開中です! 詳しく見る
222.66 USD
-1.67
0.74%
終値時点 更新済み 10月16日 16:00 EDT
プレマーケット
時間外取引
222.66
0.00
0%
1日
-0.74%
5日間
3.04%
1か月
6.08%
3か月
0.69%
6か月
1.22%
年初来
-10.95%
1年
-7.34%
5年間
-0.24%
10年間
222.65%
 

概要: Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.

従業員数: 17,937

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 42.9%
ニュートラル 52.4%
ネガティブ 4.8%
ポジティブ
Zacks Investment Research
18 時間前
Reasons to Add STE Stock to Your Portfolio Right Now
STERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.
Reasons to Add STE Stock to Your Portfolio Right Now
ニュートラル
PRNewsWire
4 日前
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
PITTSBURGH, Oct. 12, 2026 /PRNewswire/ -- Xodus Medical, a leading developer and manufacturer of innovative surgical safety solutions, today announced that it has entered into an agreement to be acquired by STERIS, a global provider of products and services that support patient care with an emphasis on infection prevention. The acquisition represents a significant milestone in Xodus Medical's more than 30-year history, bringing together two organizations with a shared commitment to advancing patient safety, supporting healthcare professionals, and delivering innovative solutions to the surgical environment.
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
ポジティブ
WSJ
4 日前
Steris to Acquire Xodus Medical for $2.1 Billion
The Dublin, Ireland provider of products and services to hospitals and pharmaceutical manufacturers said it expects the deal to expand its portfolio.
Steris to Acquire Xodus Medical for $2.1 Billion
ニュートラル
Seeking Alpha
先月
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
STERIS plc (STE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
ネガティブ
Zacks Investment Research
先月
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Steris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?
ニュートラル
GlobeNewsWire
先月
STERIS to Present at the Morgan Stanley Healthcare Conference
Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2026.
STERIS to Present at the Morgan Stanley Healthcare Conference
ポジティブ
Zacks Investment Research
先月
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
ポジティブ
Zacks Investment Research
先月
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
ニュートラル
MarketBeat
2 か月前
STERIS Q1 Earnings Call Highlights
STERIS NYSE: STE reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina.
STERIS Q1 Earnings Call Highlights
ニュートラル
Seeking Alpha
2 か月前
STERIS plc (STE) Q1 2027 Earnings Call Transcript
STERIS plc (STE) Q1 2027 Earnings Call Transcript
STERIS plc (STE) Q1 2027 Earnings Call Transcript
価格チャートは Lightweight Charts™ を使用して実装されています